KYTHERA Biopharmaceuticals Prices IPO
socalTECH
OCTOBER 11, 2012
Calabasas-based KYTHERA Biopharmaceuticals , a developer of aesthetic medicine products aimed at reducing fat deposits, has priced its IPO at $16.00 The firm is offering 4,400,000 shares of its common stock on the NASDAQ Global Select Market as KYTH. and $16.00 per share.
Let's personalize your content